Z20.1
Contact with and (suspected) exposure to tuberculosis
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code Z20.1 pertains to individuals who have come into contact with tuberculosis (TB) or are suspected of being exposed to it. This classification is used in medical records to identify cases involving potential risk of TB infection, even if the disease has not yet developed. Recognizing exposure is crucial for early monitoring and prevention of disease progression. Tuberculosis is a serious bacterial infection primarily affecting the lungs, but it can involve other parts of the body. When someone has been exposed to TB or has suspicion of exposure, healthcare providers implement specific protocols to assess and manage the risk.
Causes & Symptoms
Clinical Causes: Living with someone diagnosed with active tuberculosis Recent travel to regions with high TB prevalence Working in healthcare or laboratory settings with TB exposure risk Close contact in crowded or enclosed spaces where TB bacteria may be transmitted HIV infection or other immune-compromising conditions Inadequate screening or incomplete treatment of previous TB infection
Key Symptoms: No symptoms at all, especially in early or latent infection Persistent cough that lasts more than three weeks Coughing up blood or sputum Unexplained weight loss Night sweats and fever Fatigue and weakness Loss of appetite
Diagnostic & Treatment
Diagnosis Path: Diagnosis begins with detailed patient history to assess possible exposure sources. Healthcare providers may perform skin tests such as the Mantoux tuberculin skin test or an interferon-gamma release assay (IGRA). Chest X-rays are often utilized to detect lung involvement, and sputum samples may be analyzed to identify active bacterial infection. Since Z20.1 refers to suspected exposure, ongoing monitoring and repeated testing are typically necessary to determine if TB develops.
Treatment Protocols: While Z20.1 indicates exposure rather than active disease, individuals identified as exposed often undergo prophylactic treatment to prevent latent TB infection from progressing. This can include medications such as isoniazid or rifampin, administered over several months. Ensuring timely follow-up testing and counseling on infection control practices are essential components of management. Treatment decisions are made based on the individual's risk factors, test results, and overall health status.
Clinical Advice & FAQs
Billing Guidance
Is Z20.1 a billable ICD-10 code?
Yes, Z20.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z20.1?
Clinical documentation must specify the nature of Contact with and (suspected) exposure to tuberculosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference